INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | -33.3% | 157 | -8.2% | 0.00% | 0.0% |
| Q1 2022 | $12,000 | -40.0% | 171 | +2.4% | 0.00% | -33.3% |
| Q4 2021 | $20,000 | -4.8% | 167 | +7.7% | 0.00% | -25.0% |
| Q3 2021 | $21,000 | -8.7% | 155 | +8.4% | 0.00% | 0.0% |
| Q2 2021 | $23,000 | +187.5% | 143 | +43.0% | 0.00% | +100.0% |
| Q1 2021 | $8,000 | +60.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $5,000 | +150.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | -99.0% | 100 | -99.4% | 0.00% | -98.9% |
| Q1 2020 | $197,000 | +19.4% | 16,108 | +43.6% | 0.09% | +45.2% |
| Q4 2019 | $165,000 | +587.5% | 11,215 | +647.7% | 0.06% | +520.0% |
| Q2 2019 | $24,000 | -68.0% | 1,500 | -72.7% | 0.01% | -79.6% |
| Q4 2018 | $75,000 | -35.3% | 5,495 | +35.8% | 0.05% | -29.0% |
| Q3 2018 | $116,000 | – | 4,045 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |